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The effect of fractionation of light treatment on necrosis and vascular
function of normal skin following photodynamic therapy
K. Benstead* & J.V. Moore
Paterson Institute for Cancer Research, Christie Hospital and Holt Radium Institute, Manchester M20 9BX, UK.
Summary Sparing of normal tissue, mouse tail skin, by fractionation of light treatment in photodynamic
therapy has been demonstrated in BDF1 mice injected with 2mg tetrasodium-meso-tetra(4-sulphophenyl)
porphine dodecahydrate i.v. When the time between 2 fractions of 67.5Jcm-2 and 90Jcm-2 was increased to
2 and 4 days respectively the incidence of necrosis fell to that expected after a single fraction. Blood flow in
the tail skin 5 days after the second light fraction, as measured by the clearance of an intradermally injected
solution of 133xenon in 0.9% saline, returned to control values when the time between 2 fractions was 2 days
with 67.51Jcm-2 fractions, and 3 days with 90Jcm-2 fractions. The time course of recovery of normal mouse
tail skin from photodynamic therapy, as shown by these split dose experiments, was found to be similar to
the time course for the recovery of blood flow following a single light treatment.
Photodynamic therapy (PDT) is based on the selective
retention of certain photosensitising drugs in tumours. Expo-
sure of these tumours to light results in activation of the
drug and destruction of the tumour cells. There is evidence
that mammalian cell lines may accumulate 'sublethal
damage' on exposure to PDT. Many workers report an
initial shoulder region on curves of cell survival vs. light
dose, obtained in vitro. This has been found in experiments
using benign cell lines, e.g., Chinese hamster ovary cells
(Gomer & Smith, 1980) and human lymphocytes (Ben Hur
et al., 1987) and for cells derived from malignancies, e.g.,
NHIK cells from carcinoma in situ of the cervix (Moan et
al., 1979a) and mouse mammary carcinoma cells (Dougherty
et al., 1976). It has also been reported in experiments using
different photosensitising drugs, e.g., haematoporphyrin (HP;
Moan et al., 1979b), haematoporphyrin derivative (HPD;
Christensen et al., 1984), meso-tetra sulphophenyl porphine
(TPPS; Evensen et al., 1987) and chloroaluminium phthalo-
cyanine (Ben Hur et al., 1985).
Evidence that environmental conditions may modulate the
expression of this sublethal damage initially came from
studies on the effect of temperature on the shapes of cell
survival curves following PDT. Moan et al. (1979a) noted
that following exposure to HP, irradiation of NHIK cells in
vitro at 4°C resulted in more efficient inactivation than
irradiation at 37°C and there was no shoulder on the cell
survival curve. Subsequently, Gomer et al. (1985) demon-
strated an inhibition of repair of 'potentially lethal damage'
when Chinese hamster lung fibroblasts that had received
prolonged exposure to HPD, were held post-irradiation at
4°C or in the presence of the metabolic inhibitor caffeine.
Attempts to measure repair of sub-lethal damage by split-
dose experiments in vitro have been reported by Moan et al.
(1979a), who found that for NHIK cells exposed to light in
the presence of HP, a given total light dose was more
efficient when it was fractionated than when given in a single
exposure. Subsequently however, Christensen et al. (1985)
used the same cell line to demonstrate that relative survival
after two doses was a complex function of the interval
between doses and that 'sparing' occurred with a 3h interval.
Bellnier & Lin (1985) found that survival of EJ human
urinary bladder carcinoma cells rapidly increased with inter-
val between two light fractions, reaching a maximum at 9h.
The aim of the present study was to determine whether or
not fractionation of light treatment resulted in sparing of
tissue in vivo, using as a model normal mouse tail skin. The
photosensitiser employed was TPPS, in which there has been
*Present address: Radiotherapy Dept., Addenbrooke's Hospital,
Hills Rd., Cambridge CB2 2QQ, UK.
Correspondence: K. Benstead.
Received 22 February 1988; and in revised form, 17 May 1988.
a recent renewal of interest, both experimentally (e.g. Even-
sen et al., 1987) and clinically (Sacchini et al., 1987). Tissue
injury was assessed using two endpoints:
1. the incidence of tail necrosis, as described by Moore et
al. (1986); and
2. blood flow in the mouse tail skin 5 days after a second
light fraction as measured by the clearance of 133xenon
injected intradermally. There is evidence that impair-
ment of vascular function is an important mechanism
resulting in damage to both malignant and normal
tissues. A previous study found an initial impairment in
blood flow following PDT but this returned to normal
by day 5 at low light doses. However, at light doses
greater than the threshold for skin necrosis, there was
increasing impairment of blood flow on day 5 (Ben-
stead & Moore, 1988).
Materials and methods
Mice
9-12 week old male mice of the pigmented inbred strain
B6D2F1 were used. The animals were housed in subdued
lighting conditions under a 12h dark (1800-0600) 12h light
regimen and were supplied with food and water ad libitum.
Drug
Tetrasodium-meso-tetra (4-sulphophenyl) porphine dodeca-
hydrate (TPPS; Strem Chemicals, Newburyport, MA), a
hydrophilic agent, was dissolved in 0.9% saline. The purity
of the compound was >95%, with water and twice-
substituted products as impurities (manufacturer's infor-
mation). A dose of 2mg in a volume of 0.2ml was injected
as a bolus via the lateral tail vein. This corresponds to a
well-tolerated dose of 80mgkg-1, which is less than one
third of the LD10 dose in these mice (Moore, unpublished).
The animals were then housed in the dark for 24h.
Light source
A 100W, 12V quartz tungsten halogen lamp (Xenophot
HLX; Wotan, London) was used with a KG1 infra-red filter
(Schott, Mainz). This produced a continuous spectrum over
the range 300-1100nm with peak spectral irradiance at
approximately 700 nm. Optical lenses produced a circular
beam of uniform irradiance over a 2.5cm diameter (maxi-
mum fall off was 10%). The power density on the central
axis at the treatment distance was 75mWcm-2.
Light treatment
The animals were lightly restrained without anaesthesia in a
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perspex container. The tube containing the tail was covered
with black tape apart from the central 2.5cm. The container
was positioned with the central part of the tail across the
diameter of the light beam. Surface temperature during
illumination was measured with a thermocouple and was not
found to rise above 32.5°C.
Xenon clearance
The use of the xenon clearance technique for measurement
of blood flow in mouse tail skin following PDT has been
described previously (Benstead & Moore, 1988). In the
experiments reported here blood flow in the tails was
stimulated 15min before and during measurement by raising
ambient temperature to 37°C. The mice were restrained in a
perspex container and 5p1 of 133xenon in 0.9% saline was
injected intradermally into the distal end of the treated area.
The injection site was positioned under the centre of a
scintillation counter attached to a ratemeter and the activity
was recorded at 2 minute intervals for a minimum of 10min.
The slope of the line, obtained when the logarithm of the
remaining activity was plotted against time, was a function
of local blood flow (Kety, 1949). Results were analysed by a
computer programme to obtain the least-squares best fit for
the exponential half-time (TI) for xenon clearance.
Experimental design
1. The relationship of the interval between injection and light
treatment to the probability ofnecrosis There were 6 mice in
each experimental group and the experiments were repeated
once, the data being pooled. Groups of mice were treated
with doses of light in the range 90-202.5 Jcm-2 either 24h
or 7 days following injection of TPPS. Mice were kept for 30
days and the proportion in which the tail was lost distal to
the proximal edge of the light beam was recorded.
2. The probability of necrosis following a single light treat-
ment There were 12 mice in each experimental group.
Twenty-four hours after drug injection the mice were treated
with either 67.5 Jcm-2 or 90Jcm-2. The incidence of tail
necrosis was recorded as above.
3. The time course of impairment and recovery of bloodflow
following a single light fraction There were 12 mice in each
experimental group. Twenty-four hours after injection of
TPPS the mice were treated with either 67.5 Jcm-2 or
90JCcm-2. These doses were chosen as a single fraction was
expected to produce a low incidence of necrosis while two
consecutive fractions i.e., 135Jcm-2 and 180J cm-2, were
expected to produce a 50% and 100% incidence of tail
necrosis respectively. Values of xenon clearance T' were then
determined for different groups of animals at 10min, 4h, 1,
2, 3, 4 and 5 days following light treatment. A previous
study led us to expect that the xenon clearance TI would
return to control values by day 5 (Benstead & Moore, 1988).
4. The relationship of the time between 2 light fractions and
the probability of necrosis There were a minimum of 12
mice in each experimental group. Each group was treated
with 2 fractions of either 67.5JCcm2 or 90JCcm-2. The first
fraction was administered 24h following injection of TPPS.
The proportion of tails which necrosed was determined for
times between the 2 fractions of Omin (i.e., a single fraction
of 135 Jcm-2 or 180Jcm-2) 10min, 4h, 1, 2, 3, 4 and 5
days.
5. The relationship of the time between 2 light fractions and
the blood flow There were 12 mice in each experimental
group. After treatment with 2 light fractions of either
67.5 Jcm-2 or 90Jcm-2, the first fraction being adminis-
tered 24h after drug injection, the xenon clearance T1 was
determined for each mouse 5 days after the second light
fraction. The time between the 2 fractions was varied from
zero to 5 days as in the necrosis end-point experiments.
6. Controls Three sets of controls were used. There were a
minimum of 24 animals in each control group. (i) Xenon
clearance was performed in untreated mice. (ii) Mice were
injected with TPPS and the xenon clearance was measured
48h later. (iii) Mice were treated with 225 Jcm-2 and the
xenon clearance determined 24h later. All the control ani-
mals were observed for 30 days.
Statistical analysis
Data comparing incidence of necrosis with light dose were
analysed by a probit fitting programme (Gilbert, 1969) to
yield values for the ED50, i.e., the light dose that causes a
50% incidence of necrosis in a group of mice.
Values for xenon clearance T' were normally distributed
in the control groups and were compared by one-way
analysis of variance. The results were positively skewed in
some of the groups treated with PDT. The data were
therefore analysed by the Kruskal-Wallis test which, if
significant, was followed by multiple Mann-Whitney U tests
using a reduced significance level which allowed us to detect
where the differences between the groups were (Siegel, 1956).
Values for the number of tails undergoing necrosis with
different times between light fractions were compared using
the Chi-square test.
Results
1. Controls
There was no necrosis in the control groups. The mean value
for the xenon clearance T' at 24h for animals treated with
light only (2.9+0.92min; error as 1 s.d.) and at 48h for
animals injected with 2mg TPPS only (2.4+0.77min) were
not significantly different from the control group which had
received no treatment (2.6+0.57min). Groups treated with
both drug and light were compared statistically with
untreated controls.
2. The relationship of the time between injection and light
administration to the probability of necrosis
Probit analysis of the incidence of necrosis vs. the light dose
yielded an ED50 value of 137+ lOJcm-2 (error as 1 s.e.) for
tails exposed to light 24h after drug injection. Light treat-
ment 7 days after drug administration yielded an ED50 value
of 137+6Jcm-2. There was no significant difference between
these 2 curves.
3. The probability of necrosis following a single light
treatment
Tail necrosis occurred in 1 of the 12 mice treated with
67.5Jcm-2 and 2 of the 12 mice treated with 90Jcm-2.
4. The time course of impairment and recovery of blood
flow following a single lightfraction
Figures 1 and 2 show the mean xenon clearance T' for
different times between 10min and 5 days following light
doses of 67.5 and 90Jcm-2 respectively. The rise in the T2
at 10min following PDT with 67.5Jcm-2 was significant
(Kruskal-Wallis P<0.01). The levels then fell and by day 3
were not significantly different than the control group. The
pattern observed following PDT with a light dose of
90Jcm-2 was similar (Kruskal-Wallis P<0.01) with a signi-
ficant rise in the TI values at Omin. The values peaked at
day 2 and there was a significant fall on day 3 although at
this time the values were still significantly higher than group
control. By days 4 and 5 the levels were not significantly
different than the controls.
5. The relationship of the time between 2 light fractions and
the probability of necrosis
As shown in Figures 3 and 4, the incidence of tail necrosisEFFECTS OF PHOTODYNAMIC THERAPY ON NORMAL SKIN
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Figure 3 Incidence of tail necrosis following 2 fractions of
67.5Jcm2 the interval between the fractions varying from zero
and 5 days, 2mg TPPS i.v. per mouse. First light fraction 24h
later. Minimum of 12 mice per group.
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Figure 1 Mean xenon clearance T- at intervals between 10min
and 5 days after illumination with 67.5Jcm-2, 2mg TPPS i.v.
per mouse. Light treatment 24h later. 12 mice per group.
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Figure 2 Mean xenon clearance T-j at intervals between 10 mm
and 5 days after illumination with 90Jcm-2, 2mg TPPS i.v. per
mouse. Light treatment 24h later. 12 mice per group.
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Figure 4 Incidence of tail necrosis following 2 fractions of
90Jcm-2 the interval between the fractions varying from zero to
5 days, 2mg TPPS i.v. per mouse. First light fraction 24h later.
12 mice per group.
decreased significantly with increasing time between the 2
fractions, both with 67.5 Jcm-2 fractions (P<0.0001) and
90Jcm-2 fractions (P<0.0001). The levels had returned to
those expected after a single fraction when the time between
the fractions was increased to 2 days in the case of
67.5Jcm-2 fractions and 4 days in the case of 90Jcm-2.
6. The relationship between the time between two light
fractions and the bloodflow
There was a significant fall in the T' values as the time
between the 2 fractions of 67.5Jcm-2 was increased (Figure
5) (Kruskal-Wallis P<0.001). When there was 2 days
between the fractions the levels were not significantly differ-
ent from the controls. Similar results were obtained follow-
ing 2 fractions of 90Jcm-2, Figure 6 (Kruskal-Wallis
P<0.001). The level with 2 days between the 2 fractions,
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Discussion
We have demonstrated sparing of normal tissue by fractiona-
tion of light treatment. The incidence of tail necrosis follow-
ing 2 fractions returned to that expected following a single
fraction if the time between the fractions was increased to 2
days, in the case of a fraction size of 67.5Jcm-2 (Figure 3),
and to 4 days with 90Jcm-2 fractions (Figure 4) i.e., there
was full recovery from the initial fraction.
As demonstrated in Figures 1 and 2, the blood flow in the
tail skin was not significantly different from untreated
animals by day 5 in mice treated with a single fraction of
67.5Jcm-2 or 90JCcm-2. Therefore any impairment of blood
flow on day 5 after the second light fraction in the split dose
experiments must have been due to the effect of combining
this second fraction with an initial fraction. Recovery from
this initial fraction, as demonstrated by a return to day 5 T2
levels not significantly different from untreated controls, was
demonstrated if the time between the 2 fractions was
increased to 2 days with 67.5Jcm-2 fractions (Figure 5) and
3 days with 90Jcm-2 fractions (Figure 6).
The ED 0 remained constant when the time injection and
light treatment was prolonged from 1 to 7 days, in agree-
ment with a study by Moore (1987) on BALB/c mice. There
was no obvious depigmentation of the skin at the time of
treatment with the second light fraction. If this did occur,
however, it would be expected to reduce the sparing effect of
fractionation as there would be an increase in the light depth
dose.
It is interesting to compare the time course of recovery of
mouse tail skin following PDT, demonstrated in these split
Time beteenfracions(h)aose expenlments, witn tne time to allow compiete repair oi
Time between fractions (h) sublethal damage, 9h, observed in the in vitro experiments of
Mean xenon clearance T' 5 days following 2 fractions Bellnier et al. (1985) discussed previously. The different time
m-2, the interval beteween the fractions varying from course reported here may imply that another mechanism, in
days. 2mg TPPS i.v. per mouse. First light fraction addition to repair of sublethal damage on a cellular level,
12 mice per group. may play a part in the recovery of mouse tail skin. The
overall time required for the return of vascular function to
normal following a single light fraction (Figures 1 and 2) is
similar to the time for the skin to recover from a single
fraction as demonstrated in split dose experiments. The
recovery in vascular function after PDT reported previously
(Benstead & Moore, 1988) may be important therefore in
determining the degree of normal tissue damage when light
treatment is fractionated.
Fractionated light treatment might be used in clinical PDT
to reduce the time of treatment sessions in order to minimize
patient discomfort. Theoretically also it might be possible to
improve the therapeutic ratio of tumour to normal tissue
damage by fractionating treatment if there were differences
in the time course or capacity for repair. Several authors
have reported using fractionated courses of light treatment
following injection of HpD clinically. Dougherty (1981)
treated a patient with a basal cell carcinoma with 2 fractions
of light 4 and 5 days following drug administration. Soma et
al. (1982) gave 3 fractions at intervals of 3 weeks to a patient
with a primary carcinoma of the vagina. Ward et al. (1982)
gave multiple light fractions to patients with gynaecological
malignancies, e.g. a total of 23 treatments on days 3, 7 and
10 after drug injection to a patient with a recurrence of
carcinoma of the cervix in the vagina. Benson (1986) treated
with light at 3 and 48h following drug injection in patients
0 24 48 72 96 120 with carcinoma in situ of the bladder. There are no reports
Time between fractions (h) however of any attempt to compare the therapeutic ratios
Mean xenon clearance T2 5 days following 2 fractions achieved with single and fractionated light treatments. The
2, the interval between the fractions varying from results reported here imply that the timing of the light
idays. 2mg TPPS i.v. per mouse. First light fraction fractionation will be critical in determining the incidence of
12 mice per group. normal tissue damage.
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however, was still significantly higher than the controls but
was significantly less than the peak values. At 3 days
between the fractions the levels were not significantly differ-
ent from the controls.
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